Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biodue is a leading Italian developer and manufacturer of food supplements, medical devices, and cosmetics, primarily operating as a Contract Development and Manufacturing Organization (CDMO). Founded in 1986, the company provides end-to-end services including research, formulation, and industrial production for a global clientele. Biodue also manages a portfolio of proprietary brands such as Biofta and Selerbe, targeting therapeutic areas like ophthalmology, dermatology, and gastroenterology. The company operates multiple GMP-certified facilities in Tuscany, specializing in liquid, solid, and topical dosage forms. In 2019, Biodue was acquired by The Riverside Company and subsequently delisted from the Borsa Italiana to focus on international growth and operational scaling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biodue.